House Bill 3584
116th Congress(2019-2020)
LAB Act
Introduced
Introduced in House on Jun 27, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3584
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Scott Peters
grade
California
Alabama
Alabama
California
California
California
California
California
Connecticut
Delaware
Florida
Florida
Florida
Florida
Florida
Georgia
Georgia
Georgia
Illinois
Illinois
Illinois
Indiana
Indiana
Indiana
Indiana
Iowa
Iowa
Kentucky
Kentucky
Maryland
Michigan
Minnesota
Minnesota
Minnesota
Minnesota
Mississippi
Missouri
Missouri
Missouri
Missouri
Missouri
Nebraska
Nevada
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New York
New York
New York
North Carolina
North Carolina
North Carolina
North Carolina
North Carolina
North Carolina
North Carolina
North Carolina
Ohio
Ohio
Oklahoma
Oregon
Oregon
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Tennessee
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Vermont
Washington
West Virginia
No House votes have been held for this bill.
Summary
Laboratory Access for Beneficiaries Act or the LAB Act
This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services (CMS) for purposes of determining Medicare payment rates. The CMS must also contract with the National Academies of Sciences, Engineering, and Medicine to evaluate the methodology used to determine a specified laboratory fee schedule.
June 27, 2019
Sort by most recent
06/28/2019
Referred to the Subcommittee on Health.
06/27/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
06/27/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:50:48 PM